Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Reply to “Comments on Development and Psychometric Properties of a General Cancer Stigma Scale (COMPASS)”

AI Summary
  • Clarifies methodological issues and defends the factor analysis and item selection underpinning COMPASS against the commentators' critiques.
  • Reaffirms psychometric evidence supporting COMPASS reliability and construct validity across samples and measurement contexts.
  • Acknowledges limitations, proposes refinements, and urges independent replication and broader testing in diverse populations and settings.
Summarise with AI (MRCPsych/FRANZCP)

Int J Cancer. 2026 May 26. doi: 10.1002/ijc.70569. Online ahead of print.

NO ABSTRACT

PMID:42192219 | DOI:10.1002/ijc.70569

Document this CPD

AI Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review